Homepage > BBDC Newsletter > Vol. 12, No. 2 -- December  2011

BBDC Newsletter

BBDC NEWS   Vol. 12, No. 2 -- December 2011

MESSAGE FROM THE DIRECTOR, DR. GARY LEWIS:
BBDC PROGRAM PLANNING AND RETREAT

As previously announced, in late August this year the BBDC retained the professional consulting company SECOR to assist in an intensive planning process that will be completed by December 2011.  Dr. Zayna Khayat and Lauren Vandervoort from SECOR performed well over 70 interviews with BBDC members and key stakeholders including: directors of the U of T academic hospital research institutes; the Dean and Vice Dean of Research, Faculty of Medicine, U of T; Ministry of Health personnel and leadership responsible for the Ontario Diabetes Strategy; key diabetes scientists, educators and opinion leaders in Canada; the leadership of ICES and AHRC of the Li Ka Shing Knowledge Institute; Director of the Canadian Diabetes Association; and personnel working on the Diabetes fundraising campaigns on behalf of the Toronto General Foundation and U of T.  They also performed an extensive environmental scan of other academic diabetes institutes and centers across the globe, and drew upon the firm’s extensive experiences working with academic collaborative research enterprises.  The planning process culminated recently in a highly successful, half-day retreat held at the U of T Faculty Club, a retreat designed to develop a shared view of the long-range vision and strategy for the BBDC.  The SECOR team met weekly with the BBDC Director to review the ideas, cautionary messages and general comments of the interviewees and together with the very extensive input received at the retreat are in the final stages of developing a long-range vision for the Centre.

The final plan, once approved by the BBDC Executive, will very likely represent a radical expansion of BBDC programs with a bold vision for the future.  We continue to provide assurance that the priority that the BBDC places on supporting the training of under- and postgraduate diabetes scientists will remain our highest priority for use of our presently available funds, which will not be shifted to newer priorities. Any expansion of programs will have to occur with the acquisition of new funding.  We highlight here three of the ~10 ideas that have emerged through this process, and rationale behind those ideas:

  • We have much to gain from developing research themes and programs, with multidisciplinary clusters of scientists working in close collaboration, and in collaboration with researchers in other disciplines across U of T.  These themes have been identified in the planning process using a set of predefined criteria and based on our existing research strength.  The funding agencies such as CIHR are moving towards an Integrated Knowledge Translation (IKT) approach, CFI grants are awarded to teams working on cutting edge research topics and our fundraising from philanthropic donors and industry is highly dependent on our ability to interest and excite donors with cutting-edge ideas that can make an impact on specific diseases.  It is essential that we organize ourselves into these programs and work together since it will become more and more difficult over time for the 20th century-style ‘independent investigator’ to continue to remain competitive if working in isolation.
  • Despite the fact that we have some highly successful individual diabetes clinical trialists in Toronto, the BBDC has not traditionally had a strong track record in clinical trials and clinical research.  We are currently punching way below our weight in this important area of research.  Instead of building parallel infrastructure at enormous expense we have the full support of the Li Ka Shing Applied Health Research Centre (AHRC) and the clinical trials platform recently created by our colleagues in the Division of Cardiology at U of T.  With the full support of their leadership, this will allow us to leapfrog over many hurdles, and to much more rapidly become leaders in diabetes clinical trials.
  • In addition to the research prowess of U of T faculty, our faculty contains some of the finest teachers, educators and innovators in the field of health care policy, knowledge translation and health care delivery.  It will in no way dilute our fundamental research capability for the BBDC to become a Centre for Innovation in Diabetes Disease Care and Education.  In fact we found tremendous enthusiasm amongst our existing membership for expanding our programs in this arena and have already linked up with others in the U of T community who are much more advanced than us in their development of exciting programs in Quality Improvement Science, Global Health, e-Health innovation, Complex Care Innovation and other areas of Knowledge Translation.  The Canadian Diabetes Association is interested in partnering with us in some of these ventures and we will also look outside U of T to partner with others who are working in these areas, such as those at York University and at UWO. There is a big gap in this area to be filled by an academic Centre such as the BBDC

The above is just a titillating taste of what you are likely to see when we present our more detailed and specific long range vision and plan to you within the next few months.


INSULIN: Toronto's Gift to the World, a permanent display of artefacts from the discovery of insulin

The University of Toronto marked 90 years of excellence in diabetes research on October 26, 2011 with the unveiling of INSULIN: Toronto’s Gift to the World, a permanent exhibit in Toronto’s MaRS Centre that tells the story of the discovery of insulin. A product of collaboration among U of T’s Department of Physiology, Toronto General Hospital (now part of the University Health Network) and what later became U of T’s Banting and Best Department of Medical Research, the discovery of insulin set U of T Medicine on a course of innovation which continues to this day. The exhibit includes a video; two information panels; Frederick Banting’s desk; a lab bench; a replica of the 1923 Nobel Prize in Medicine; letters of correspondence; a timeline; vials of insulin from the 1920s through the present, lab instruments and other historical artefacts. The University of Toronto’s Faculty of Medicine curated the exhibit in partnership with the University Health Network and MaRS. The permanent exhibit is located on the ground floor of the MaRS Centre, 101 College Street, Toronto, northeast corner of the building, across the hall from Mercatto restaurant (view a map).
[Above photo by Patrice Banton, courtesy of iQ inc.]

Read the Toronto Star story on the exhibit (October 26, 2011) 
View the Toronto Star’s insulin exhibit photo gallery   
Watch a video about the exhibit's creation by CBC's The National


UPCOMING EVENTS

MANAGEMENT OF DIABETES IN THE PATIENT WITH CHRONIC KIDNEY DISEASE:  A Workshop for Health Care Professionals Working in Diabetes Care and Education

Save the date.  The Banting & Best Diabetes Centre will be hosting a workshop on Friday, April 20, 2012 from approximately 9:15 a.m. to 12:00 p.m. at the Toronto General Hospital.  The focus of the workshop will be on the interprofessional management of the patient with diabetes with comorbid kidney disease.  Content will include: an update on diabetic nephropathy, balancing diabetes and renal nutritional needs, and adjusting antihyperglycemic medications in renal disease. Moderators will lead breakout sessions emphasizing the interprofessional roles involved in the management of patients with diabetes and: 1) microalbuminuria or proteinuria, 2) impaired renal function (pre-dialysis), 3) on dialysis.  The workshop is being offered to diabetes health care professionals who work at University of Toronto fully and community affiliated institutions.  It is intended for health care professionals who work in diabetes care or education or health care professionals who manage patients with kidney disease (i.e. nurses, dietitians, physicians, pharmacists, social workers, rehabilitation specialists).  In order to maximize interaction with participants, registration will be limited to approximately 35 participants and will be accepted on a first come, first served basis. The complete program and registration information will be available in late January 2012.

23RD ANNUAL SCIENTIFIC DAY

Mark your calendar.  The BBDC’s 23rd Annual Scientific Day will be held on Friday, May 11, 2012 from 8 a.m. to 3 p.m. at the Old Mill Inn, Toronto. This annual event is open to BBDC members, their trainees, and U of T endocrine residents.  This year's Charles Hollenberg Memorial Lectureship will be delivered by Dr. Gokhan Hotamisligil from the Harvard School of Public Health.  The program will also include University of Toronto faculty and staff Drs. Richard Bazinet, Daniel Drucker, Chee-Tin Christine Lee, James Scholey, and Dan Winer. BBDC postdoctoral fellowship and graduate studentship recipients, as well as selected Annual Trainee Awards Competition abstract submitters will present posters of their work.  We are delighted to announce that twelve pre-selected posters will be judged by Dr. Randy Levinson, Senior Editor of Nature Medicine at the Scientific Day. The Annual Trainee Awards prize winners will be announced and prizes will be presented to the recipients by Dr. Levinson at the end of the Scientific Day program.  Registration information will be available in March 2012.  View the preliminary program at http://www.bbdc.org/pdf/SciDay2012Prelim.pdf

BBDC SEMINAR SERIES 2011/2012

The BBDC will be hosting the following diabetes-related seminars which are held in conjunction with City-wide Endocrine Rounds. The seminars are held on selected Friday mornings from 8 to 9 a.m. at the Mount Sinai Hospital, Lebovic Building, 60 Murray Street, 3rd floor conference room.  Faculty wishing to meet with any of the visiting speakers should contact Dr. Tony Lam at tony.lam@uhnres.utoronto.ca . Speakers will include:

Friday, February 17, 2012

Branched Chain Amino Acid Sensing in Diabetes
Christopher B. Newgard, PhD
Director, Sarah W. Stedman Nutrition and Metabolism Center
W. David and Sarah W. Stedman Distinguished Professor
Duke University Medical Center

Friday, April 20, 2012

Regulation of Glucose Homeostasis by the Bone
Gerard Karsenty, MD, PhD
Professor and Chair, Department of Genetics and Development
Columbia University Medical Center

FUNDING OPPORTUNITIES

CHARLES HOLLENBERG SUMMER STUDENTSHIP PROGRAM 2012

A limited number of summer studentships are available for undergraduate and medical students to carry out research in diabetes under the supervision of a  member of the Banting & Best Diabetes Centre.  Students will be required to work for a minimum of 12 weeks between May 1 and August 31, 2012. To be eligible, the proposed supervisor must hold a full-time faculty appointment with the University of Toronto, and must be conducting diabetes research.  The proposed supervisor must also be a registered member* of the BBDC at the time of application submission.  A list of potential supervisors and their e-mail addresses is available on the BBDC’s web site at http://www.bbdc.org/pdf/2012_SummerSupervisors.doc. Students may also directly contact other faculty with whom they are interested in working to discuss the possibility of a summer position.  The deadline for receipt of applications is 5 p.m., January 24, 2012.  For complete award details and application instructions see the following web page: http://www.bbdc.org/fundingOpp/summer.htm .

ANNUAL TRAINEE AWARDS 2011/2012

U of T graduate, undergraduate, and medical students, postdoctoral and clinical fellows and medical residents are invited to submit an abstract for this competition.  NEW THIS YEAR: All 2011/2012 BBDC Graduate Studentship and Post-doctoral Fellowship recipients are required to submit an abstract of their work for this competition. Trainees who are not funded by the BBDC are also invited to submit an abstract. To be eligible, the trainee must be first author and the content of the abstract must specifically state the direct relevance of the work to diabetes. The trainee's supervisor must hold a full-time faculty appointment with the University of Toronto, and must be a registered member* of the BBDC at the time of abstract submission.  Members of the BBDC Research Committee will screen all abstracts submitted to this competition.  The best twelve abstracts will be selected for poster judging at the BBDC Annual Scientific Day to be held on Friday, May 11, 2012.  We are delighted to announce that the twelve posters will be judged by Dr. Randy Levinson, Senior Editor of Nature Medicine, during the morning poster session. The prize winners will be announced and prizes will be presented to the recipients by Dr. Levinson at the end of the Scientific Day program. (Please note: All 2011/2012 BBDC Graduate Studentship and Post-doctoral Fellowship recipients must present a poster at the Scientific Day regardless of whether or not their abstract is one of the twelve selected to be judged by Dr. Levinson. Non-BBDC funded individuals who submit an abstract and are selected as one of the twelve to be judged by Dr. Levinson will present a poster at the Scientific Day.)  The deadline for receipt of applications is 5 p.m., January 31, 2012.  For complete award details and application instructions see the following web page: http://www.bbdc.org/fundingOpp/abstract.htm .

BBDC POSTDOCTORAL FELLOWSHIPS 2012/2013
HUGH SELLERS POSTDOCTORAL FELLOWSHIP 2012/2013
BBDC FELLOWSHIPS IN DIABETES CARE 2012/2013

The BBDC will be awarding a number of postdoctoral fellowships to candidates at the post-PhD or post-MD degree stages.  The one-year fellowships (normally commencing on July 1, 2012and no later than September 1, 2012) are to be used for full-time research training in diabetes.  To be eligible, the candidate's proposed supervisor must hold a full-time faculty appointment with the University of Toronto and must be conducting diabetes research.  The proposed supervisor must be a registered member* of the BBDC at the time of application submission.  Candidates must have received a PhD  after July 2008, or an MD after July 2003 and must be within their first four (4) years of postgraduate research training.  The deadline for receipt of applications is 5 p.m., February 22, 2012.   For complete award details and application instructions, please see the following web page: http://www.bbdc.org/fundingOpp/fellowships.htm .

ARCHIE SOPMAN DIABETES RESEARCH AND EDUCATION AWARDS 2012
(For University Health Network Employees Only)

This funding program is only open to University Health Network (UHN) staff physicians, dietitians, nurses, social workers, pharmacists, or scientists who are primarily involved in diabetes research, education or clinical care.  Funding is available for travel to one national or international diabetes meeting occurring in the year 2012, or to support a visiting lecturer in diabetes or metabolic disorders visiting in the year 2012.  To be eligible to apply, applicants must be employed by the UHN on a full-time basis.  The principal applicant must also be a registered member* of the BBDC at the time of application submission. The deadline for receipt of applications is 5 p.m., March 20, 2012.   For complete award details and application instructions, please see the following webpage:  http://www.bbdc.org/fundingOpp/sopman.htm .

TRAINEE TRAVEL AWARDS 2011/2012 (PERIOD 2)
FOR TRAVEL OCCURRING BETWEEN JANUARY 1 AND JUNE 30, 2012

Awards of up to $1,000 (Canadian) are available to trainees who will be traveling to a national or international meeting between January 1 and June 30, 2012 to present a first-author abstract.  The content of the abstract must specifically state the direct relevance of the work to diabetes.  At the time of abstract submission to the meeting, the applicant must be either: A) a registered University of Toronto graduate, undergraduate or medical student;  B) a post-doctoral fellow having received a PhD within the last 5 years; or  C) a medical resident or clinical fellow having received an MD within the last 9 years.  The applicant’s supervisor must hold a full-time faculty appointment with the University of Toronto and must also be a registered member* of the BBDC at the time of application submission.  Applications must be received by 5 p.m., March 27, 2012.  For complete award details and application instructions please see the following web page: http://www.bbdc.org/fundingOpp/travel.htm .

UPCOMING FUNDING OPPORTUNITIES

Information on the following programs will be posted on the BBDC’s website in the coming months:

  • Graduate Studentships 2012/2013. Application deadline: June 5, 2012

*Those who are new to the field of diabetes research, education or care and are not members of the BBDC can request free membership by contacting the Centre prior to submitting an application.  For more information about BBDC Membership, please view the MEMBERSHIP section of our web site at http://www.bbdc.org/membership/index.htm.


AWARD RESULTS**

TRAINEE TRAVEL AWARDS 2011/2012 - PERIOD 1
For Travel Occurring between July 1 and December 31, 2011

Applicant Supervisor Abstract Title
Li-Hao Chen Dr. Andrew Advani The Diabetic Subtotally, Nephrectomized Rat is a Novel Model of Renal Dysfunction in Diabetes Characterized by Heavy Proteinuria and GFR Decline
Ting (Tim) Chiu Dr. Amira Klip Regulation of actin dynamics by the Rac-dependent effectors, Arp2/3 and PAK is required for insulin-stimulated GLUT4 translocation in muscle cells
Mark Dekker Dr. Khosrow Adeli Inhibition of sphingolipid synthesis improves dyslipidemia in the insulin resistant/hyperlipidemic hamster model
Fei Fang Dr. James Scholey Obesity and Diabetic Nephropathy: Interactions between Adiponectin and Angiotensin II in Human Renal Tubular Cells
Bibiana Garcia-Bailo Dr. Ahmed El-Sohemy Vitamin D Status and Biomarkers of Type II Diabetes Risk in an Ethnically Diverse Population
S. Mohsen Hosseini Dr. Andrew Paterson Using time-to-event analysis for genome-wide association study in a long-term cohort of diabetic retinopathy
Joanne Hseih Dr. Khosrow Adeli Intracelular communications mediating GLP-2-stimulated intestinal chylomicron secretion
Ya-Chi Huang Dr. Herbert Gaisano In situ electrophysiological examination of pancreatic alpha-cells in type 1 diabetes revealing the cellular basis of glucagon hypersecretion
George Chu Liu Dr. James Scholey Deletion of p47phox Reduces Progression of Diabetic Nephropathy in the Akita Mouse
Sandra Pereira Dr. Adria Giacca Inhibitors of endoplasmic reticulum stress prevent hepatic insulin resistance induced by prolonged lipid infusion
Qiaozhu Su Dr. Khosrow Adeli Mitochondrial stress coupled with CREBH induced hepatic insulin resistance
Yi Sun Dr. Amira Klip Possible effectors of Rab proteins in insulin-induced GLUT4 translocation in L6 muscle cells
Wylie Tan Dr. Carol Westall Visual Electrophysiology Markers Demonstrate a Progressive Dysfunction of the Retina in Adolescents With Type 1 Diabetes

**An essential condition of all BBDC programs is the acknowledgement of BBDC support, where appropriate, in all publications and presentations relevant to the BBDC-supported research program.  Failure to appropriately acknowledge the BBDC in relevant publications and presentations will be considered grounds for suspending future eligibility for BBDC funding programs.


BBDC CORE LABORATORY

The BBDC Core Laboratory provides analytical and technical support to the University of Toronto diabetes research community.  A wide range of research quality assays and services are provided for investigator initiated clinical or basic research as well as for industry sponsored trials.  Please see the Core Laboratory section of the BBDC’s web site at http://www.bbdc.org/laboratories/index.htm for a complete description of assays and services currently available.


BBDC membership is free and open to individuals involved in full or part-time diabetes research, education, and patient care (i.e. scientists, physicians, nurses, dietitians, pharmacists, etc.), and whose primary appointment/employment (more than 50% of total salary) is with the University of Toronto or one of its affiliated institutions. Staff at both fully and partially affiliated institutions are eligible to apply for membership.  For more information about BBDC membership, please view the MEMBERSHIP section of our web site at http://www.bbdc.org/membership/index.htm.


BBDC News is published in September, December, March and June of each year.
Current and past issues are available on our web site at www.bbdc.org/newsletter/index.htm.

DIRECTOR: GARY LEWIS, MD, FRCPC
Banting & Best Diabetes Centre
Faculty of Medicine, University of Toronto
Located at the Toronto General Hospital
200 Elizabeth Street
Eaton Building, 12th Floor, Room 12E248
Toronto, Ontario M5G 2C4
Phone: (416) 978-4656 • Fax: (416) 978-4108
E-mail:
diabetes.bbdc@utoronto.ca • Web site: www.bbdc.org